What Is Grey Market Premium (GMP) — and Can You Actually Trust It?

Every time a hot IPO opens, one number gets whispered everywhere: the GMP. People treat it like a sneak peek at listing day — "GMP is ₹100, so you'll make ₹100 a share on day one." It's tempting. It's also where a lot of new investors get burned.

What GMP actually is

GMP stands for Grey Market Premium. It's the extra amount buyers are willing to pay for an IPO share before it officially lists — traded in an unofficial, off-the-record market.

Think of it like tickets to a sold-out concert. The face value is ₹1,000, but scalpers outside are charging ₹1,400. That ₹400 markup is the "premium" — a rough signal of how badly people want in. GMP is the same idea for IPO shares: if the issue price is ₹100 and the GMP is ₹20, the grey market is betting the stock lists around ₹120.

Where the number even comes from

Here's the part most people skip. This grey market isn't a real exchange. SEBI doesn't regulate it, and the stock exchanges don't track it. There's no official screen showing the price.

The GMP you see on websites is basically a handful of dealers reporting what a tiny number of off-market deals are going for. A few hundred trades are being used to guess the mood of lakhs of applicants. It runs entirely on trust and word of mouth — which means it can be thin, swayed by hype, or simply wrong.

Why you shouldn't treat it as a promise

GMP often gets the direction right — a strong positive GMP usually means a stock will list up, a negative one usually means a weak debut. But the exact number is regularly off, and sometimes it flips entirely.

The grey market reacts to buzz, not to the actual demand that shows up once real money is on the line. Sentiment can sour overnight — a bad market day, weak final subscription, or global jitters — and a premium that looked rock-solid can vanish by listing morning.

A real example: Godavari Biorefineries (2024)

In October 2024, Godavari Biorefineries launched a ₹555 crore IPO at an issue price of ₹352 a share. The grey market was positive — GMP hovered around ₹15–25, suggesting the stock would list flat to slightly up. Applicants expecting a small pop felt safe.

Listing day told a different story. The stock opened at ₹308 — a 12.5% discount to the issue price. Instead of the modest gain the GMP implied, day-one buyers were sitting on a loss. And Godavari wasn't alone that year: plenty of 2024 IPOs listed well below what their grey market premiums had hinted.

The lesson isn't that GMP is useless — it's a mood reading, nothing more. Treat it like the buzz outside a theatre, not a guaranteed payout. The only things that truly decide an IPO's worth are the company's business and the price you paid for it.